AYTU BIOPHARMA, INC Cash and Restricted Cash
AYTU BIOPHARMA, INC (AYTU) had Cash and Restricted Cash of $19.80 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-05-15
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.80M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.50M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.96M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.98M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2024-03-31 | $19.80M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $19.50M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $19.96M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $22.98M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $19.18M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $19.50M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $23.81M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $19.36M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $27.61M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $35.28M 10-Q · filed 2023-02-21 | |
| 2021-09-30 | $40.56M 10-Q/A · filed 2023-02-21 | |
| 2021-06-30 | $49.90M 10-K · filed 2023-10-12 | $49.90M 10-K · filed 2021-09-28 |
| 2021-03-31 | $46.79M 10-Q · filed 2022-05-16 | $46.80M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $62.28M 10-Q · filed 2022-02-14 | $62.30M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $38.16M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $48.33M 10-K · filed 2022-09-27 | |
| 2018-06-30 | $7.10M 10-K · filed 2018-09-06 | |
| 2018-03-31 | $12.08M 10-Q · filed 2018-05-14 | |
| 2017-06-30 | $877.54K 10-Q · filed 2018-05-14 | |
| 2017-03-31 | $3.55M 10-Q · filed 2018-05-14 | |
| 2016-06-30 | $8.05M 10-Q · filed 2018-05-14 | |
| 2015-06-30 | $7.35M 10-K · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |